Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma

Pancreas

Volumn 42, Issue 6, 2013, Pages 1016-1026

  Samuel, Nardin ^a,b   Sayad, Azin ^c   Wilson, Gavin ^b   Lemire, Mathieu ^b   Brown, Kevin R ^a,b   Muthuswamy, Lakshmi ^b   Hudson, Thomas J ^a,b   Moffat, Jason ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

driver gene; ECT2; pancreatic cancer; RNA interference; somatic copy number gain

Indexed keywords

K RAS PROTEIN; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR GATA 6;

ARTICLE; CELL VIABILITY; CHROMOSOME 18Q; CHROMOSOME 3Q; COPY NUMBER VARIATION; GENE LOCUS; GENETIC ANALYSIS; GENOMICS; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA GENE; RNA INTERFERENCE; TRANSCRIPTOMICS; UPREGULATION;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; DNA COPY NUMBER VARIATIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; MOLECULAR TARGETED THERAPY; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RNA INTERFERENCE; TRANSCRIPTOME;

EID: 84880677913     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318287d043     Document Type: Article

References (35)

1. Yeo TP, Hruban RH, Leach SD, et al. Pancreatic cancer. Curr Probl Cancer. 2002;26(4):176-275.
2. Jemal A, Seigel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
3. Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15:2403-2413.
4. Hezel AF, Kimmelman AC, Stanger BZ, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006;20(10): 1218-1249.
5. Feldmann G, Maitra A. Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts. J Mol Diagn. 2008;10(2):111-122.
6. Gräntzdörffer I, Carl-McGrath S, Ebert MP, et al. Proteomics of pancreatic cancer. Pancreas. 2008;36(4):329-336.
7. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674.
8. Harada T, Chelala C, Crnogorac-Jurcevic T, et al. Genome-wide analysis of pancreatic cancer using microarray-based techniques. Pancreatology. 2009;9(1-2):13-24.
9. Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008;321:1801-1806.
10. Fu B, Luo M, Lakkur S, et al. Frequent genomic copy number gain and overexpression of GATA-6 in pancreatic carcinoma. Cancer Biol Ther. 2008;7(10):1593-1601.
11. Kimmelman AC, Hezel AF, Aguirre AJ, et al. Genomic alterations link Rho family GTPases to the highly invasive phenotype of pancreas cancer. Proc Natl Acad Sci USA. 2008;105(49):19372-19377.
12. Baudis M. Genomic imbalances in 5918 malignant epithelial tumors: an explorative meta-analysis of chromosomal CGH data. BMC Cancer. 2007;18:7-226.
13. Samuel N, Hudson TJ. The molecular and cellular heterogeneity of pancreatic ductal adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2011;9(2):77-87.
14. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nature Genetics. 2005;37:S11-S17.
15. Moffat J, Gruenberg DA, Yang X, et al. A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell. 2006;124(6):1283-1298.
16. Marcotte R, Brown KR, Suarez F, et al. Essential gene profiles in breast, pancreas and ovarian cancer cells. Cancer Discovery. 2012; 2(2):172-189.
17. International Cancer Genome Consortium Data Coordination Center [ICGC Web site]. 2012. Available at: http://dcc.icgc.org/. Accessed January 9, 2010.
18. Olshen AB, Venkatraman ES, Lucito R, et al. Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics. 2004;5(4):557-572.
19. Li A, Liu Z, Lezdon-Geyda K, et al. GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays. Nucleic Acids Res. 2011;39(12):4928-4941.
20. Lin SM, Du P, Huber W, et al. Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res. 2008; 36(2):e11.
21. Pinto D, Darvishi K, Shi X, et al. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol. 2011;29(6):512-520.
22. Heidenblad M, Jonson T, Mahlamaki EH, et al. Detailed genomic mapping and expression analysis of 12p amplifications in pancreatic carcinomas reveal a 3.5-Mb target region for amplification. Genes Chromosomes Cancer. 2002;34(2):211-223.
23. Beroukhim R, Mermel CH, Porter D, et al. The landscape of somatic copy-number alterations across human cancers. Nature. 2010; 463:899-905.
24. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011; 364(19):1817-1825.
25. Pegram M, Slamon D. Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapy. Semin Oncol. 2000;27(9):13-19.
26. Ring G, Khoury CM, Solar AJ, et al. Transmembrane protein 85 from both human (TMEM85) and yeast (YGL231c) inhibit hydrogen peroxide mediated cell death in yeast. FEBS Lett. 2008; 582(17):2637-2642.
27. Hirano Y, Hendil KB, Yashiroda H, et al. A heterodimeric complex that promotes assembly of mammalian 20S proteasome. Nature. 2005; 437(7063):1381-1385.
28. Salhia B, Tran NL, Chan A, et al. The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma. Am J Pathol. 2008;173(6):1828-1838.
29. Sano M, Genkai N, Yajima N, et al. Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep. 2006;16(5):1093-1098.
30. Hirata D, Yamabuki T, Miki D, et al. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression. Clin Cancer Res. 2009;15(1):256-266.
31. Justilien V, Fields AP. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene. 2009; 28(41):3597-3607.
32. Iyoda M, Kasamatsu A, Ishigami T, et al. Epithelial cell transforming sequence 2 in human oral cancer. PLoS One. 2010;5(11):e14082.
33. Haverty PM, Hon LS, Kaminker JS, et al. High-resolution analysis of copy number alterations and associated expression changes in ovarian tumors. BMC Med Genomics. 2009;2:21.
34. Wang Z, Li Y, Ahmad A, et al. Pancreatic cancer: understanding and overcoming chemoresistance. Nat Rev Gastroenterol Hepatol. 2011;8:27-33.
35. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366(10):883-892.